Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib
Titel:
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib
Auteur:
White, Maya N. Piper-Vallillo, Andrew J Gardner, Rebecca M. Cunanan, Kristen Neal, Joel W. Das, Millie Padda, Sukhmani K. Ramchandran, Kavitha Chen, Thomas T. Sequist, Lecia V. Piotrowska, Zofia Wakelee, Heather A.